# Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation

> **NCT03198741** · PHASE4 · COMPLETED · sponsor: **Shenyang Northern Hospital** · enrollment: 783 (actual)

## Conditions studied

- Gastrointestinal Injury
- Ischemic Heart Disease

## Interventions

- **DRUG:** Aspirin + clopidogrel
- **DRUG:** Clopidogrel monotherapy
- **DRUG:** Aspirin monotherapy

## Key facts

- **NCT ID:** NCT03198741
- **Lead sponsor:** Shenyang Northern Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-13
- **Primary completion:** 2020-08-13
- **Final completion:** 2020-08-13
- **Target enrollment:** 783 (ACTUAL)
- **Last updated:** 2022-05-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03198741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03198741, "Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03198741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*